摘要
背景:自武汉首次报告以来,当前的2019冠状病毒病(COVID-19)大流行激励了全球努力制定有效的COVID-19疫苗接种策略。编码COVID-19抗原的mRNA疫苗因其高效和简单的制造工艺而在这场全球竞赛中脱颖而出。值得注意的是,两种COVID-19 mRNA疫苗mRNA-1273和BNT162b2在临床试验中存活下来,并获准在各国紧急使用。 综述:从这个角度讨论了COVID-19 mRNA疫苗的最新进展,包括序列设计、化学修饰、生产工艺和体内交付。总结mRNA-1273和BNT162b2的I期至IV期临床试验。 结论:mRNA疫苗是实现COVID-19大流行大规模疫苗接种的一种有前景的策略。我们希望未来mRNA疫苗技术的研究能够克服现有的局限性,帮助人们应对COVID-19。
关键词: 新冠肺炎(COVID-19), SARS-CoV-2, mRNA疫苗,化学修饰,mRNA- 1273, BNT162b2。
Current Medicinal Chemistry
Title:Perspectives and Prospects on mRNA Vaccine Development for COVID-19
Volume: 29 Issue: 23
关键词: 新冠肺炎(COVID-19), SARS-CoV-2, mRNA疫苗,化学修饰,mRNA- 1273, BNT162b2。
摘要:
Background: The current coronavirus disease 2019 (COVID-19) pandemic, since first reported in Wuhan, has inspired worldwide efforts to develop effective COVID-19 vaccination strategies. mRNA vaccines encoding COVID-19 antigens have emerged prominantlyin this global race due to their high effectiveness and simple manufacturing process. Notably, two COVID-19 mRNA vaccines, mRNA-1273 and BNT162b2, have survived in clinical trials and been authorized for emergency use across variouscountries.
Summary: Recent advances on mRNA vaccine development for COVID-19 are discussed in this perspective, including sequence design, chemical modification, manufacturing process, and in vivo delivery. Phase I to IV clinical trials of mRNA-1273 and BNT162b2 are then summarized, respectively.
Conclusion: Using mRNA vaccines is a promising strategy to achieve mass vaccination in the COVID-19 pandemic. We hope that future studies of mRNA vaccine technology will overcome existing limitations and help people cope with COVID-19.
Export Options
About this article
Cite this article as:
Perspectives and Prospects on mRNA Vaccine Development for COVID-19, Current Medicinal Chemistry 2022; 29 (23) . https://dx.doi.org/10.2174/0929867329666220216110931
DOI https://dx.doi.org/10.2174/0929867329666220216110931 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Differences in Relative Levels of 88 microRNAs in Various Regions of the Normal Adult Human Brain
MicroRNA Legumes: A Healthy and Ecological Source of Flavonoids
Current Nutrition & Food Science Breath Tests to Assess Alcoholic Liver Disease
Reviews on Recent Clinical Trials The Tumor Suppressor Gene ARF as a Sensor of Oxidative Stress
Current Molecular Medicine Toxins Targeting Voltage-Activated Ca<sup>2+</sup> Channels and their Potential Biomedical Applications
Current Topics in Medicinal Chemistry Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies
Current Medicinal Chemistry Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Current Topics in Medicinal Chemistry Herb-Drug Interactions and Mechanistic and Clinical Considerations
Current Drug Metabolism Hormone Responsive Breast Cancer and BRCA1 Mutation: Mechanism, Regulation and Iron-mediated Effects
Current Pharmaceutical Biotechnology A Glycemic Threshold of 90 mg/dl Promotes Early Signs of Atherosclerosis in Apparetly Healthy Overweight/Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Current Cancer Drug Targets Introduction to the Special Issue “Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence” and a Summary of Patents Targeting other Neurotransmitter Systems
Recent Patents on CNS Drug Discovery (Discontinued) Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors
Current Pharmaceutical Design Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Current Alzheimer Research Patent Selections:
Recent Patents on Biotechnology Imidazoline Receptor Agonists in Obesity-Related Hypertension: Therapeutic Targeting of the Sympathetic Nervous System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
Current Drug Discovery Technologies Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry Specific Recognition of DNA by Small Molecules
Current Medicinal Chemistry